Full Text | PDF

Theranostics 2022; 12(14):6155-6156. doi:10.7150/thno.77186 This issue Cite

Erratum

Preventing tumor progression to the bone by induced tumor-suppressing MSCs: Erratum

Xun Sun^1,2, Kexin Li^1,2, Rongrong Zha^1,2, Shengzhi Liu², Yao Fan^1,2, Di Wu^1,2, Misato Hase^2,3, Uma K. Aryal⁴, Chien-Chi Lin^2,5, Bai-Yan Li^1✉, Hiroki Yokota^1,2,5,6✉

1. Department of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
2. Department of Biomedical Engineering, Indiana University Purdue University Indianapolis, Indianapolis, IN 46202, USA.
3. Graduate School of Engineering, Mie University, Mie 514, Japan.
4. Department of Comparative Pathobiology, Purdue University, West Lafayette, IN 47907, USA.
5. Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
6. Indiana Center for Musculoskeletal Health, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

✉ Corresponding authors: Hiroki Yokota, PhD, Department of Biomedical Engineering, Indiana U. Purdue U. Indianapolis, 723 West Michigan Street, SL220, Indianapolis, IN 46202 USA. Phone: 317-278-5177, Fax: 317-278-2455, E-mail: hyokotaedu; Bai-Yan Li, MD/PhD, Department of Pharmacology, School of Pharmacy, Harbin Medical University, #157 Baojian Road, Harbin 150081, China. Phone/Fax: +86 451-8667-134, E-mail: libyhrbmu.edu.cn. More

Corrected-article in Theranostics, Volume 11, 5143

Citation styles

©2024 Ivyspring International Publisher. Terms of use